The Heart Transplantation Market is projected to reach USD 25.67 billion by 2033, up from USD 11.25 billion in 2023, representing a compound annual growth rate (CAGR) of 10.32% over the period. This market encompasses the healthcare sector dedicated to the surgical replacement of a diseased or failing heart with a donor heart. It includes a range of components such as medical devices, pharmaceuticals, and healthcare services related to heart transplantation.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Surgery Type (Total Artificial Heart, Biventricular Pacing, Heart Restraint Devices, Ventricular Assist Devices, Other)
By End Use (Hospitals, Cardiac institutes, Research Centers, Laboratories, Other)
Key players
Abbott Laboratories
ABIOMED
Berlin Heart
BiVACOR Inc.
Calon Cardio
CareDx Inc
CARMAT
CorWave SA
HeartWare
SynCardia Systems LLC
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook